Lunit is expanding its deployment of an AI imaging solution to South Korean military facilities and troops overseas.
Share: email Subscribe
Weekly Top Stories Tue, 23 May 2023
We have 30 articles this week, # Calyxt Announces Stockholder Approval of Merger With Cibus #ArisGlobal Acquires SPORIFY to Expand Regulatory Solutions .#Biodexa Pharmaceuticals Enters into Nonbinding Letter of Intent for Proposed Acquisition of Varian Biopharmaceuticals #Oncomatryx acquires Tube Pharmaceuticals GmbH to consolidate its pioneering pipeline of ADCs targeting the tumor microenvironment. #Alimera Acquires U.S. Commercial Rights to YUTIQ® #Myeloid Therapeutics Announces $73 Million Financing to Advance mRNA-based Immunotherapy Pipeline.
Editor's Choice
1. 
 Lunit Expands AI Deployment in Military Facilities Overseas
2. 
 Fertility App Premom Shared Users’ Health Data Without Consent, FTC Says
3. 
 Emcure Pharmaceuticals Launches Injectable to Treat Iron Deficiency in India
4. 
 Menopause Care Platform Gennev Becomes Aetna In-Network Provider
5. 
 DocGo Shares Rise Amid Q1 Financial Results and More Digital Health Earnings.
Top 10 M&A Transactions
6. 
 Calyxt Announces Stockholder Approval of Merger With Cibus
7. 
 ArisGlobal Acquires SPORIFY to Expand Regulatory Solutions
8. 
 Biodexa Pharmaceuticals Enters into Non-binding Letter of Intent for Proposed Acquisition of Varian Biopharmaceuticals
9. 
 Oncomatryx Acquires Tube Pharmaceuticals GmbH to Consolidate its Pioneering Pipeline of ADCs Targeting the Tumor Microenvironment
10. 
 Alimera Acquires U.S. Commercial Rights to YUTIQ®
11. 
 Myeloid Therapeutics Announces $73 Million Financing to Advance mRNA-based Immunotherapy Pipeline
12. 
 Amgen ‘Remains Committed’ to $27.8B Horizon Acquisition After FTC Challenge
13. 
 Horizon Therapeutics plc Responds to U.S. Federal Trade Commission (FTC) Action to Block Acquisition by Amgen
14. 
 Waters Corporation Completes Acquisition of Light Scattering Leader Wyatt Technology
15. 
 Pharma Retail Emerges New Frontier for Organised Players
Top 4 Venture Funding
16. 
 Singaporean Telehealth Startup ORA Nets $10M in Series A Funding
17. 
 Pear Therapeutics Assets Sold for $6M at Auction After Bankruptcy.
18. 
 Adonis Secures $17M for Revenue Cycle Automation Platform
19. 
 Hippocratic AI Launches with $50M to Build Large Language Model for Healthcare
Top 4 Partnerships Announcements
20. 
 Professional Soccer Players Score Telehealth Partner for Mental Health
21. 
 Included Health, DispatchHealth Partner to Offer Virtual-to-in-home Care
22. 
 Tampa General, Henry Ford, Patient like me , Other Digital Health Partnerships
23. 
 Amazon’s One Medical Partners with Rightway to Expand Primary Care Access
Read More Corporate Development and M&A Activity
Get Featured: Send us your article or blog and we will feature it on our publication, reach over thousands of executives. Click Here.
Editor: Ed Francis

Ed has more than 25 years of management consulting experience and currently is the Global Managing Partner for Infosys Consulting Health and Life Sciences business guiding some of the industry's most prominent health and life sciences organizations through complex transformations.

If you need help with your complex transformation whether it be M&A, digital, or strategic cost reduction or need to bring more innovation into your business strategy Ed can be contacted at Edward.Francis@infosys.com and +1-847-910-6073

Or connect with him at

OTHER ADVISORIES

Health Plan Hospital IT
IT GovHealth
Retail POP Health
Ageing Life Sciences

Advertise with us

We Reach Half Million Decision Makers in:
Healthcare · IT · Retail · Industrial
Advertise with us and reach the right audience.
advertise@distilnfo.com

Contact Us

5760 Legacy Dr, B3-405,
Plano TX 75024
+1 469-270-3311

DistilINFO Publications

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you - saving time and keeping you up to date on your interest areas.

You are receiving this newsletter because you are subscribed to one or more DistilINFO Publications Newsletter/s. If you feel this email was sent by mistake or you want to opt out, you can unsubscribe.

View in browser | Advertise | Contact Us